Essential medicines and health products

Measuring transparency to improve good governance:

in the public pharmaceutical sector, a comparative analysis of five country assessment studies (Bolivia, Cambodia, Indonesia, Mongolia, Papua New Guinea)

Measuring transparency to improve good governance in the public pharmaceutical sector

Publication details

Number of pages: 59
Publication date: January 2009
Languages: English
WHO reference number: WHO/PSM/PAR/2008.5

Access to good quality essential medicines is still very limited in many parts of the world. Market failures, government inefficiencies, poverty, war and corruption are among the underlying causes of the problem. Corruption is gaining increasing attention and more people recognize the need for a transparent and accountable environment in order to have effective social, political and economic development. The pharmaceutical sector has been identified as one that is highly vulnerable to corruption and unethical practices...